Egyptian Drug Authority · Egypt
DEA-EG-2022-0007
Tier 1 · Regulator-publishedUnclassifiedRecallStatus · active
- Issuing authority
- Egyptian Drug Authority (EDA)
- Authority reference
- Periodic report no.(7) For 2022
- Date issued
- 06 Apr 2022
- Recorded by us
- 2026-09-06 19:45:29 UTC
- Product
- DINCEDATRIC ANTI SEPTIC 7.5%
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- Manufacturer
- Not stated by the issuing authority
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- Batch numbers
- 210139
- Expiry dates
- Not published with the notice
- Action type
- Recall
- Classification
- Not stated by the issuing authority
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- Not stated by the issuing authority
- Product type
- Not stated by the issuing authority
- ATC code
- Not stated by the issuing authority
- Affected markets
- Egypt — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- Notice text
- @egyptiandrugauthority
www.edaegypt.gov.eg
15301
٦ ابريل ٢٢٠٢
وذلك لكون المســـتحضر صادر له عـــدم مطابقة نهائية من معامل
هيئة الدواء المصرية
وعليـــه يتعين الالتـــزام بما جاء بعاليه وعلى شـــركات التوزيع تجميد
الأرصدة الموجودة لديهم من ذلك المســـتحضر التي ينطبق عليها
المواصفات.
DINCEDATRIC ANTI SEPTIC 7.5%
210139رقم التشغيلة
الشركة المصنعة للمستحضر : بانكس
HELWAN PHARMA EGYPTلصالح شركة
يتم ضبط وتحريز العبوات من المستحضر التالي:
منشور
غير مطابق
DINCEDATRIC
ANTI SEPTIC 7.5%Original language: ar
- Notice text in English
- Non-conformity circular. The packs of the following product are to be impounded and seized: DINCEDATRIC ANTI SEPTIC 7.5%, batch number 210139. Manufactured by Banks for Helwan Pharma Egypt. A final finding of non-conformity has been issued for the product by the laboratories of the Egyptian Drug Authority. The above must be complied with, and distribution companies must freeze the stocks they hold of the affected product. Dated 6 April 2022.Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
- Status
- Active
- Superseded by
- Not superseded. This is the current version.
- Version
- 1
Where this record came from, and what is held to show it.
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- 7e3600ef0a36dfac447aba399f743ecaca6c2cd717099b40f9adab382ec1f76cSHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-09-06 20:35:37 UTC
Cite this record
Drug Eye Africa (2022). DEA-EG-2022-0007: DINCEDATRIC ANTI SEPTIC 7.5% — Recall, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2022/dea-eg-2022-0007Version history
—No version history recorded for this record.
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.